Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lucky No. 35? Sarepta And BioMarin Settle Global Patent Disputes

Handshake of businessmen

Related Content

Sarepta Wins Exon 51 Composition Patent Rights Over BioMarin

Sep 22 2016

BioMarin to pay $840m for GSK castoff

Nov 24 2014

Sarepta's Shadow: BioMarin Mulls Turning The Extraordinary Into A Template

Oct 15 2016

Duchenne Surprise: Sarepta Prices Exondys 51 Below Expectations

Sep 20 2016

Related Companies

Sarepta Therapeutics, Inc.

BioMarin Pharmaceutical Inc.

Prosensa Holding N.V

Additional Topics

Intellectual Property Legal Issues Rare Diseases Commercial Deals BioPharmaceutical

More from Legal & IP

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window